Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
31.32
+1.28 (4.26%)
Nov 22, 2024, 4:00 PM EST - Market closed
Simulations Plus Employees
As of August 31, 2024, Simulations Plus had 247 total employees, including 243 full-time and 4 part-time employees. The number of employees increased by 50 or 25.38% compared to the previous year.
Employees
247
Change (1Y)
50
Growth (1Y)
25.38%
Revenue / Employee
$283,453
Profits / Employee
$40,300
Market Cap
628.50M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| InnovAge Holding | 2,350 |
| Phathom Pharmaceuticals | 452 |
| OrthoPediatrics | 247 |
| Omeros | 198 |
| EyePoint Pharmaceuticals | 121 |
| Altimmune | 59 |
| Dianthus Therapeutics | 53 |
| Oculis Holding AG | 36 |
SLP News
- 4 days ago - Simulations Plus to Participate in the BTIG Digital Health Forum - Business Wire
- 10 days ago - Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables - Business Wire
- 17 days ago - Simulations Plus to Participate in the Stephens Annual Investment Conference - Business Wire
- 24 days ago - Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations - Business Wire
- 4 weeks ago - Simulations Plus, Inc. (SLP) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results - Business Wire
- 6 weeks ago - Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date - Business Wire
- 6 weeks ago - Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings - Business Wire